CAJ | 학술논문

1型糖尿病是一种自身免疫性疾病,在高血糖发生前,胰岛β细胞已经被破坏.学者们在免疫治疗研究方面取得了许多新的突破.本文就近几年在1型糖尿病特异性抗原、抗体、细胞学及其他免疫治疗方面所取得的最新进展进行概述.
1형당뇨병시일충자신면역성질병,재고혈당발생전,이도β세포이경피파배.학자문재면역치료연구방면취득료허다신적돌파.본문취근궤년재1형당뇨병특이성항원、항체、세포학급기타면역치료방면소취득적최신진전진행개술.
Type 1 diabetes mellitus(T1DM) is a chronic autoimmune disease.Prospective studies carried out in T1 DM pre-diabetic relatives have shown that the process of β-cell degeneration can take place before the disease manifests itself clinically.Scholars have made several breakthroughs in immune therapy for T1 DM.This paper will make a review of the latest progress in the antigen-specific,antibody-based,cell-based,and other immunotherapies of T1DM.